Copaxone is owned by Teva....All news received directly from Teva or it's websites is in green
Thursday
Supreme Court to decide patent dispute over Copaxone
Read how Teva's rivals Mylan Inc., Momenta Pharmaceuticals Inc. and Sandoz, Inc., will be able to start selling generic versions of the drug later this year, after the remaining patents on the drug expire. Click here to read more